Transcriptional expression and gelatinolytic activity of matrix metalloproteinases in Henoch-Schonlein purpura

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 8, 2010, Pages 1248-1252

  Mahajan, N ^a   Bisht, D ^a   Dhawan, V ^a   Singh, S ^a   Minz, R W ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Henoch Schonlein purpura; Matrix metalloprotienases; Transcriptional expression; Zymography

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE;

ANAPHYLACTOID PURPURA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SYSTEMIC VASCULITIS; ZYMOGRAPHY;

CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GELATIN; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PURPURA, SCHOENLEIN-HENOCH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIBLINGS; TRANSCRIPTION, GENETIC;

EID: 77954380808     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01781.x     Document Type: Article

References (21)

1. Miller ML, Pachman L. Vasculitis syndromes. In : Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. 17th ed.
2. Cassidy JT, Petty RE. Leukocytoclastic vasculitis. In : Cassidy JT, Petty RE, Laxer RM, Lindsley CB, editors. Textbook of pediatric rheumatology, 5th ed.
3. Kumar L, Singh S, Goraya JS, Uppal B, Kakkar S, Walker R, et al. Henoch-Schonlein purpura: The Chandigarh Experience. Indian J Pediatr 1998 35 : 19 27.
4. Bagga A, Kabra SK, Shrivastva RN, Bhuyan UN. Henoch-Schonlein Purpura in Northern Indian Children. Indian J Pediatr 1991 28 : 1153 1157.
5. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem Pharmacol 2008 75 : 346 359.
6. Sorbi D, French DL, Nuovo GJ, Kew RR, Arbeit LA, Gruber BL. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum 1996 39 : 1747 1753.
7. Takeshita S, Tokutomi T, Kawasae H, Nakatani K, Tsujimoto H, Kamamura Y, et al. Elevated serum levels of matrix metalloproteinase-9 (MMP 9) in Kawasaki disease. Clin Exp Immunol 2001 125 : 340 344.
8. Chua PK, Meish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol 2003 110 : 308 314.
9. Nikkari ST, Hoyhtya M, Isola J, Nikkari T. Macrophages contain 92-KD gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996 149 : 1427 1433.
10. Mahajan N, Dhawan V, Malik S, Jain S. Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's Arteritis disease. Int J Cardiol 2009 doi :.
11. Ozen S, Ruperto N, Dillon MJ. EULAR/PreS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006 65 : 936 941.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 254.
13. Mahajan N, Dhawan V. C-reactive protein (CRP) - induced up-regulation of MMPs and their tissue inhibitor in THP-1cells: Inhibitory effects of Atorvastatin. Mol Cell Biochem. doi :.
14. Mahajan V, Singh S, Khullar M, Minz RW. Serum and urine nitric oxide levels in children with Henoch-Schonlein purpura during activity and remission: a study from North India. Rheumatol Int 2009 29 : 1069 1072.
15. Davin JC, Weening JJ. Diagnosis of Henoch-Schonlein purpura: renal or skin biopsy? Pediatr Nephrol 2003 18 : 1201 1203.
16. Zou CC, Zhao ZY, Tang LF, Liang L. Plasma levels of matrix metalloproteinase-9 in Henoch- Schönlein purpura. Scand J Rheumatol 2006 35 : 52 5.
17. Tashiro K, Koyanagi I, Ohara I, Ito T, Saitoh A, Horikoshi S, et al. Levels of urinary matrix metalloproteinase-9 (MMP-9) and renal injuries in patients with type 2 diabetic nephropathy. J Clin Lab Anal 2004 18 : 206 210. (Pubitemid 38585800)
18. Rao VH, Lees GE, Kashtan CE, Nemori R, Singh RK, Meehan DT. Increased expression of MMP-2, MMP-9 (type IV collagenases/gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int 2003 63 : 1736 1748.
19. Vine N, Powell JT. Metalloproteinases in degenerative aortic disease. Clin Sci 1991 816 : 233 239.
20. Davies MJ. Aortic aneurysm formation: lessons from human studies and experimental models. Circulation 1998 98 : 193 195.
21. Guo Y, Peng X, Lei S. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin 2008 40 : 426 436.